TITLE

The leucotriene receptor antagonist montelukast and the risk of Churg-Strauss syndrome: a case— crossover study

AUTHOR(S)
Hauser, T.; Mahr, A.; Metzler, C.; Coste, J.; Sommerstein, R.; Gross, W. L.; Guillevin, L.; Hellmich, B.
PUB. DATE
August 2008
SOURCE
Thorax;Aug2008, Vol. 63 Issue 8, p677
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background: There has been some concern that leucotriene receptor antagonists might precipitate the onset of Churg-Strauss syndrome (CSS). A study was undertaken to investigate the relationship between the leucotriene receptor antagonist montelukast and the onset of CSS. Methods: Medication histories of 78 patients with CSS from France and Germany were retraced by questioning the patients, treating physicians and dispensing pharmacists, and from medical records. Using a case-crossover research design, exposures to montelukast and other asthma medications during the 3-month "index" period immediately preceding the onset of CSS were compared with those of four previous 3-month "control" periods. Odds ratios (ORs) were computed by conditional logistic regression. Results: The ORs for CSS onset were 4.5 (95% Cl 1.5 to 13.9) for montelukast, 3.0 (95% Cl 0.8 to 10.5) for inhaled long-acting β2 agonists, 1.7 (95% Cl 0.5 to 5.4) for inhaled corticosteroids and 4.0 (95% Cl 1.3 to 12.5) for oral corticosteroids. Montelukast exposure during control periods increased temporally over three consecutive calendar periods of CSS onset from 1999 to 2003 (ptrend <0.0001). Conclusion: Montelukast use was associated with a 4.5- fold higher risk of CSS onset within 3 months. However, the positive estimates obtained for other long-term asthma control medications suggest that this link might be confounded by a general escalation of asthma therapy before CSS onset. The association between montelukast and CSS observed in this study is probably also explained by the increasing use of this medication over time.
ACCESSION #
34153257

 

Related Articles

  • Churg-Strauss syndrome and the leukotriene receptor antagonist pranlukast. Shimbo, Junsuke; Onodera, Osamu; Tanaka, Keiko; Tsuji, Shoji // Clinical Rheumatology;Dec2005, Vol. 24 Issue 6, p661 

    The authors studied eight cases of Churg-Strauss syndrome (CSS) associated with the use of pranlukast, a common cysteinyl leukotriene receptor antagonist (LTRA) in Japan. The patients who received pranlukast showed significantly increased peripheral blood eosinophil count, neurological...

  • Churg-Strauss syndrome complicated by endomyocardial fibrosis and intraventricular thrombus. Importance of the echocardiography for the diagnosis of asymptomatic phases of potentially severe cardiac complications. Le�n-Ru�z, L; Jim�nez-Alonso, J; Hidalgo-Tenorio, C; D�az-Ricom�, N; P�rez-Alvarez, A. F.; Le�n-Villaverde, B; Concha-L�pez, A; Lara-Torrano, J // Lupus;2002, Vol. 11 Issue 11, p765 

    Presents a case report of allergic angiitis and granulomatosis or Churg-Strauss Syndrome (CSS). Differential diagnosis between CSS and other vasculitides; Rarity of documented cases of complications arising from eosinophilic endomyocarditis; Cases of CSS with complications such as thrombus in...

  • Granulomatous arteritis in cutaneous lesions of Churg-Strauss syndrome.  // Current Medical Literature: Dermatology;2007, Vol. 12 Issue 3, p78 

    An abstract of the article "Granulomatous arteritis in cutaneous lesions of Churg-Strauss syndrome," by K. R. Chen, M. Sakamoto and K. Ikemoto is presented.

  • Implication of ANCA status in Churg-Strauss syndrome. Gareeboo, S. // Thorax;Mar2006, Vol. 61 Issue 3, p270 

    The article discusses an abstract of the article "Antineutrophil cytoplasmic antibodies and the Churg-Strauss syndrome," by R. Sable-Fourtassau, P. Cohen, A. Mahr and colleagues, published in the "Annals of Internal Medicine"

  • Difficult asthma or Churg-Strauss syndrome? D'Cruz, David P; Barnes, Neil C; Lockwood, C Martin // BMJ: British Medical Journal (International Edition);02/20/99, Vol. 318 Issue 7182, p475 

    Editorial. Discusses the pathophysiology of difficult asthma or Churg-Strauss syndrome. Clinical trials of pharmacological agents; Information about the syndrome; Account of related studies.

  • A Purpuric Rash and Mononeuritis Multiplex. Winchester, David E.; Guilliams, Kristin // American Family Physician;2/15/2008, Vol. 77 Issue 4, p501 

    A quiz about purpuric rash and mononeuritis multiplex is presented.

  • Pulmonary puzzle.  // Thorax;Mar2010, Vol. 65 Issue 3, p270 

    The article offers information on the answer to a pulmonary puzzle regarding Churg-Strauss syndrome (CSS), diagnosed based on extensive vasculitis in a sural nerve biopsy.

  • CHURG-STRAUSS SYNDROME. Ghosh, Subhasish; Bhattacharya, Maitreyee; Dhar, Sandipan // Indian Journal of Dermatology;Nov/Dec2011, Vol. 56 Issue 6, p718 

    Churg-Strauss syndrome (CSS) is a rare granulomatous necrotizing small vessel vasculitis characterized by the presence of asthma, sinusitis, and hypereosinophilia. The cause of this allergic angiitis and granulomatosis is unknown. Other common manifestations are pulmonary infiltrates, skin,...

  • Deflazacort.  // Reactions Weekly;7/18/2009, Issue 1261, p13 

    The article describes the case of deflazacort-induced Churg-Strauss syndrome in a 12-year-old boy with immunoglobulin A (IgA) nephropathy. It references a study by H. E. Yim et al, published in a 2009 issue of the journal "Clinical Nephrology." The medical history of the patient is presented....

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics